IRBESARTAN/HYDROCHLOROTHIAZIDE MYLAN PHARMA 150 mg/12,5 mg, comprimé pelliculé — plaquette(s) PVC polyéthylène PVDC aluminium de 30 comprimé(s)

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400921782165
  • CIP7 2178216
  • CIS 67399371

What the source publishes

Holder
MYLAN SAS
Active ingredients
HYDROCHLOROTHIAZIDE, IRBÉSARTAN
Form
comprimé pelliculé
Package
plaquette(s) PVC polyéthylène PVDC aluminium de 30 comprimé(s)
Routes
orale
Administrative status
cancelled
Supply regime
liste I
Marketing status
Déclaration d'arrêt de commercialisation
Authorised on
2011-11-15
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400921782165
{
  "cis": "67399371",
  "cip7": "2178216",
  "form": "comprimé pelliculé",
  "name": "IRBESARTAN/HYDROCHLOROTHIAZIDE MYLAN PHARMA 150 mg/12,5 mg, comprimé pelliculé — plaquette(s) PVC polyéthylène PVDC aluminium de 30 comprimé(s)",
  "cip13": "3400921782165",
  "holder": "MYLAN SAS",
  "routes": [
    "orale"
  ],
  "holders": [
    "MYLAN SAS"
  ],
  "currency": "EUR",
  "marketed": false,
  "bdmStatus": "Warning disponibilité",
  "useDomain": "unknown",
  "publicPrice": null,
  "authorisedOn": "2011-11-15",
  "compositions": [
    {
      "name": "HYDROCHLOROTHIAZIDE",
      "nature": "SA",
      "strength": "12,5 mg",
      "linkageNumber": "2",
      "substanceCode": "02064",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    },
    {
      "name": "IRBÉSARTAN",
      "nature": "SA",
      "strength": "150 mg",
      "linkageNumber": "1",
      "substanceCode": "31416",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "liste I",
  "dispensingFee": null,
  "medicinePrice": null,
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "IRBESARTAN/HYDROCHLOROTHIAZIDE MYLAN PHARMA 150 mg/12,5 mg, comprimé pelliculé",
  "marketingStatus": "Déclaration d'arrêt de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-11-20",
    "CIS_CIP_bdpm": "2026-11-20",
    "CIS_CPD_bdpm": "2026-11-20",
    "CIS_COMPO_bdpm": "2026-11-20"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "non",
  "packageDescription": "plaquette(s) PVC polyéthylène PVDC aluminium de 30 comprimé(s)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [],
  "marketingDeclaredOn": "2021-12-22",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "cancelled",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "HYDROCHLOROTHIAZIDE",
    "IRBÉSARTAN"
  ],
  "authorisationProcedure": "Procédure décentralisée",
  "prescriptionConditions": [
    "liste I"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation abrogée",
  "europeanAuthorisationNumber": null,
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400921782165"